{"contraindications":{"vaccineGroup":{"contraindication":[{"observationCode":"095","observationTitle":"Severe allergic reaction after previous dose of Meningococcal","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Meningococcal vaccine."},{"observationCode":"080","observationTitle":"Adverse reaction to vaccine component","contraindicationText":"Do not vaccinate if the patient has had an adverse reaction to a vaccine component."}]},"vaccine":{"contraindication":[{"observationCode":"154","observationTitle":"HIV/AIDS - severely immunocompromised","contraindicationText":"Do not vaccinate with Meningococcal MCV4P (Menactra) if the patient is between the ages of 9 months and 2 years and is severely immunocompromised due to HIV/AIDS.","contraindicationGuidance":"n/a","contraindicatedVaccine":[{"vaccineType":"Meningococcal, MCV4P","cvx":"114","beginAge":"2 months","endAge":"2 years"}]},{"observationCode":"155","observationTitle":"HIV/AIDS - not severely immunocompromised","contraindicationText":"Do not vaccinate with Meningococcal MCV4P (Menactra) if the patient is between the ages of 9 months and 2 years and is severely immunocompromised due to HIV/AIDS.","contraindicationGuidance":"n/a","contraindicatedVaccine":[{"vaccineType":"Meningococcal, MCV4P","cvx":"114","beginAge":"2 months","endAge":"2 years"}]},{"observationCode":"160","observationTitle":"Anatomical or functional asplenia","contraindicationText":"Do not vaccinate with Meningococcal MCV4P (Menactra) if the patient is between the ages of 9 months and 2 years and has anatomical or functional asplenia.","contraindicationGuidance":"n/a","contraindicatedVaccine":[{"vaccineType":"Meningococcal, MCV4P","cvx":"114","beginAge":"2 months","endAge":"2 years"}]},{"observationCode":"117","observationTitle":"Severe allergic reaction to diphtheria toxoid","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to diphtheria toxoid.","contraindicationGuidance":"n/a","contraindicatedVaccine":[{"vaccineType":"Meningococcal, MCV4P","cvx":"114"},{"vaccineType":"Meningococcal, MCV4O","cvx":"136"}]},{"observationCode":"118","observationTitle":"Severe allergic reaction to tetanus toxoid","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to tetanus toxoid.","contraindicationGuidance":"n/a","contraindicatedVaccine":[{"vaccineType":"Meningococcal Polysaccharide A, C, Y, W-135 TT Conjugate"}]}]}},"series":[{"seriesName":"Meningococcal ACWY 2-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesType":"Standard"},{"seriesName":"Meningococcal ACWY risk start before 7 months 4-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesAdminGuidance":["If MenACWY-D is used, it should be administered at least 4 weeks after completion of all PCV doses."],"seriesType":"Risk"},{"seriesName":"Meningococcal ACWY risk start after 7 months 2-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesAdminGuidance":["If MenACWY-D is used, it should be administered at least 4 weeks after completion of all PCV doses."],"seriesType":"Risk"},{"seriesName":"Meningococcal ACWY risk Hib-MenCY-TT 4-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesType":"Risk"},{"seriesName":"Meningococcal ACWY risk 2-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesAdminGuidance":["If MenACWY-D is used, it should be administered at least 4 weeks after completion of all PCV doses."],"seriesType":"Risk"},{"seriesName":"Meningococcal ACWY risk 1-dose series","targetDisease":"Meningococcal","vaccineGroup":"Meningococcal","seriesAdminGuidance":["If MenACWY-D is used, it should be administered at least 4 weeks after completion of all PCV doses. "]}]}